Scientists have announced the world’s first stem cell treatment for spina bifida, a debilitating birth defect that results in lifelong disability. The treatment was delivered during fetal surgery and appears to offer a significant improvement in quality of life for affected infants.
Spina bifida is a birth defect in which the spinal cord fails to develop properly. This results in lifelong disability and a range of difficulties including loss of sensation, muscle weakness, and incontinence. There is currently no cure for spina bifida, but treatment can improve quality of life.
The world’s first stem cell treatment for spina bifida was delivered during fetal surgery. Fetal surgery is a highly complex and risky procedure, but it offers the best chance of improving outcomes for infants with spina bifida.
The treatment involves injecting stem cells into the developing spinal cord. The stem cells help to repair the damage caused by spina bifida and improve the function of the spinal cord.
The fetal surgery was performed on a pregnant woman at 28 weeks of gestation. The surgery was successful and the baby was born healthy at 38 weeks.
The baby girl, who has not been named, is now four months old and doing well. She is able to sit up, crawl, and even stand with support.
The treatment is still in its early stages and will need to be repeated in order to confirm its efficacy. However, the initial results are very promising and offer hope for a better quality of life for infants with spina bifida.
A groundbreaking new treatment for spina bifida has been successfully delivered during fetal surgery, in a world first.
The treatment, which involves injecting stem cells into the developing spinal cord of the fetus, has the potential to dramatically improve the quality of life for those affected by the condition.
Around 1 in 1,000 babies are born with spina bifida, a birth defect that occurs when the spine and spinal cord do not develop properly. This can lead to a range of problems including paralysis, incontinence and deformity.
Current treatment options are limited, but the new stem cell therapy offers hope for those affected.
The stem cells used in the treatment are derived from the patients themselves, meaning that there is no risk of rejection. This is a significant advantage over current treatments, which often involve using donor cells.
So far, the treatment has been successfully delivered to three fetuses, with all three babies born without any complications.
The long-term effects of the treatment are not yet known, but the early results are extremely promising. It is hoped that this treatment will eventually become the standard of care for spina bifida, providing hope for countless families.